These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2156617)

  • 1. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
    Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ
    Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
    Banda MJ; Howard EW; Herron GS; Apodaca G
    Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
    Sharma RK
    In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.
    DeClerck YA; Yean TD; Chan D; Shimada H; Langley KE
    Cancer Res; 1991 Apr; 51(8):2151-7. PubMed ID: 2009533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells.
    Rossi M; Rooprai HK; Maidment SL; Rucklidge GJ; Pilkington GJ
    Anticancer Res; 1996; 16(1):121-8. PubMed ID: 8615596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.
    Brown PD; Levy AT; Margulies IM; Liotta LA; Stetler-Stevenson WG
    Cancer Res; 1990 Oct; 50(19):6184-91. PubMed ID: 2169338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
    Moll UM; Youngleib GL; Rosinski KB; Quigley JP
    Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
    Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
    Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation.
    Welgus HG; Senior RM; Parks WC; Kahn AJ; Ley TJ; Shapiro SD; Campbell EJ
    Matrix Suppl; 1992; 1():363-7. PubMed ID: 1480061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M; Miyamori H; Yamashita J; Sato H
    Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
    Alexander JP; Samples JR; Van Buskirk EM; Acott TS
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cultured neurons release an inhibitor of astroglia proliferation (astrostatine).
    Rogister B; Leprince P; Bonhomme V; Rigo JM; Delree P; Colige A; Moonen G
    J Neurosci Res; 1990 Jan; 25(1):58-70. PubMed ID: 2319623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
    Alexander JP; Bradley JM; Gabourel JD; Acott TS
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.
    Tanaka K; Iwamoto Y; Ito Y; Ishibashi T; Nakabeppu Y; Sekiguchi M; Sugioka Y
    Cancer Res; 1995 Jul; 55(13):2927-35. PubMed ID: 7796421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
    Lokeshwar BL; Selzer MG; Block NL; Gunja-Smith Z
    Cancer Res; 1993 Oct; 53(19):4493-8. PubMed ID: 7691397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor cell collagenolytic activity by bovine endothelial cells.
    DeClerck YA; Laug WE
    Cancer Res; 1986 Jul; 46(7):3580-6. PubMed ID: 3708589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.